In addition, activation of NF-κB in macrophages could exacerbate insulin insensitivity and affect glucose metabolism, and involves in metabolic disorders including obesity, insulin resistance, type 2 diabetes, and atherosclerosis[17–19]. Here, NFKB1 is linked to Insulin resistance.